Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in India
Venus , Remedies , Metx , Critical , Antibiotic , Development , Will , Therapeutics , Resistance , …
Venus , Remedies , Metx , Critical , Antibiotic , Development , Will , Therapeutics , Resistance , …
syngene international invests in dedicated peptide laboratory and advanced automation Acce…
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installe…
Scientists unveil world-leading technology to speed up drug discovery Newcastle University deve…
India , Drug , From , Granules , Approval , Company , Limited , Pharmaceutical , Information , Chan…
Class , India , Scholarship , State , Development , Launches , the , 2024 , Education , Scheme , …
India’s Quantum leap with 85% of Industry leaders calling for major investments in Quantum Comput…